# ERYTHROMYCIN
> **ANDA208100** · Abbreviated New Drug Application (Generic) · Sponsor: PAI HOLDINGS PHARM · Approved 2017-11-20
## Drug
- **FDA Application Number:** ANDA208100
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ERYTHROMYCIN
- **Generic name:** Erythromycin
- **Active ingredients:** ERYTHROMYCIN
- **Dosage form:** SOLUTION
- **Route:** TOPICAL
- **Marketing status:** Discontinued
- **Sponsor:** PAI HOLDINGS PHARM
- **First approval:** 2017-11-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208100)
---
*MORVS · CC0 1.0*